BackCitius Pharmaceuticals- Warrants(02/08/2022) Overview

Citius Pharmaceuticals- Warrants(02/08/2022) Inventory

Citius Pharmaceuticals- Warrants(02/08/2022)'s inventory is $23M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$22.66M
47.72% YoYΔ $7.32M vs prior year quarter

Peer average / median

Loading

Citius Pharmaceuticals- Warrants(02/08/2022) Inventory History

Loading

Citius Pharmaceuticals- Warrants(02/08/2022) vs. peers: Inventory Comparison

Loading

Citius Pharmaceuticals- Warrants(02/08/2022) Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Citius Pharmaceuticals- Warrants(02/08/2022) (CTXRW) FAQ

As of the most recent data (March 2026), CTXRW shows a inventory of $23M. That compares with $15M in the prior-year period — up 47.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CTXRW's inventory is now $23M (was $15M) — a 47.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Citius Pharmaceuticals- Warrants(02/08/2022) is outperforming or lagging.

Tracking CTXRW's inventory over time shows whether Citius Pharmaceuticals- Warrants(02/08/2022) is scaling, shrinking, or reshaping that part of the business. The current reading is $23M That compares with $15M in the prior-year period — up 47.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Citius Pharmaceuticals- Warrants(02/08/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $23M) with ownership activity and broader fundamentals.

Citius Pharmaceuticals- Warrants(02/08/2022)'s inventory is $23M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.